Literature DB >> 18777411

Dosimetric verification of RapidArc treatment delivery.

Stine Korreman1, Joakim Medin, Flemming Kjaer-Kristoffersen.   

Abstract

PURPOSE: Recently, Varian Medical Systems have announced the introduction of a new treatment technique, in which dose is delivered over a single gantry rotation with variable MLC positions, dose rate and gantry speed. In February 2008, a preclinical installation of the RapidArc beam delivery approach was carried out on a Varian Clinac at Rigshospitalet in Copenhagen. The purpose of the installation was to perform measurements to verify the correctness of doses delivered with the RapidArc technique. In May 2008, the clinical release of the RapidArc application was installed at Rigshospitalet. METHODS AND MATERIALS: Nine treatment plans were generated in the Eclipse version 8.5 including the RapidArc optimizer for H&N and prostate cases. The plans were delivered to the Scandidos Delta4 cylindrical diode array phantom. First, the measured dose distributions were compared with the calculated doses. All plans were then delivered several times to verify consistency of the delivery. Gamma analysis was used to verify the correspondence between dose distributions. The temporal resolution of the delivery was analysed by investigating the arc segments between control points separately.
RESULTS: Overall, good agreement was observed between measured and calculated doses in most cases with gamma values above 1 in >95% of measured points. The reproducibility of delivery was also very high. Gamma analysis between two consecutive runs of the same delivery plan generally showed gamma values above 1 in none of the measured points, and dose deviation less than 1%. Temporal analysis showed small discrepancies between doses delivered between control points (approximately 2 degrees of the rotation) in consecutive runs of a plan, however these were cancelled out in the accumulated dose.
CONCLUSION: The delivery of RapidArc beam delivery has been verified to correspond well with calculated dose distributions for a number of different cases. The delivery was very reproducible, and was carried out with high stability of the accelerator performance.

Entities:  

Mesh:

Year:  2009        PMID: 18777411     DOI: 10.1080/02841860802287116

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  29 in total

1.  The dosimetric impact of inversely optimized arc radiotherapy plan modulation for real-time dynamic MLC tracking delivery.

Authors:  Marianne Falk; Tobias Larsson; Paul Keall; Byung Chul Cho; Marianne Aznar; Stine Korreman; Per Poulsen; Per Munck Af Rosenschold
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

2.  Deep learning-augmented radiotherapy visualization with a cylindrical radioluminescence system.

Authors:  Mengyu Jia; Xiaomeng Li; Yan Wu; Yong Yang; Priya Kasimbeg; Lawrie Skinner; Lei Wang; Lei Xing
Journal:  Phys Med Biol       Date:  2021-02-09       Impact factor: 3.609

3.  Time-resolved dose distributions to moving targets during volumetric modulated arc therapy with and without dynamic MLC tracking.

Authors:  Thomas Ravkilde; Paul J Keall; Cai Grau; Morten Høyer; Per R Poulsen
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

4.  Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.

Authors:  X Jin; H Yan; C Han; Y Zhou; J Yi; C Xie
Journal:  Br J Radiol       Date:  2014-12-10       Impact factor: 3.039

5.  Commissioning and Acceptance Testing of the existing linear accelerator upgraded to volumetric modulated arc therapy.

Authors:  Ekambaram Varadharajan; Velayudham Ramasubramanian
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-06

6.  Dosimetry challenges for implementing emerging technologies.

Authors:  Fang-Fang Yin; Mark Oldham; Jing Cai; Qiuwen Wu
Journal:  J Phys Conf Ser       Date:  2010

7.  Real-time dynamic MLC tracking for inversely optimized arc radiotherapy.

Authors:  Marianne Falk; Per Munck af Rosenschöld; Paul Keall; Herbert Cattell; Byung Chul Cho; Per Poulsen; Sergey Povzner; Amit Sawant; Jens Zimmerman; Stine Korreman
Journal:  Radiother Oncol       Date:  2010-01-19       Impact factor: 6.280

8.  Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.

Authors:  Barbara Dobler; Karin Weidner; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2010-10-25       Impact factor: 3.481

9.  Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters.

Authors:  Akihiro Haga; Akira Sakumi; Yukari Okano; Saori Itoh; Naoya Saotome; Satoshi Kida; Hiroshi Igaki; Kenshiro Shiraishi; Hideomi Yamashita; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiol Phys Technol       Date:  2013-03-12

10.  Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy.

Authors:  Giorgia Nicolini; Alessandro Clivio; Antonella Fogliata; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2009-07-24       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.